D
DiaMedica Therapeutics Inc.
DMAC · NASDAQ · Healthcare · 360M
Closing price
$8.33
+4.00% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
7.0×
Enterprise value / EBITDAEV/EBITDA
-11.5×
Free cash flow yieldFCF yield
-7.4%
Return on equityROE
-58.4%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.5×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.